Center Laboratories AAQS
The The AAQS of Center Laboratories (4123.TWO) as of Oct 18, 2026 is 3. In the previous year, The AAQS was 3.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
3
YoY
0.00%
Last updated:
Center Laboratories has a current AAQS of 3.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Center Laboratories in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Center Laboratories in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Center Laboratories AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2018
3.00 TWD
Jan 1, 2019
3.00 TWD
Jan 1, 2020
3.00 TWD
Jan 1, 2021
3.00 TWD
Jan 1, 2022
3.00 TWD
Jan 1, 2023
3.00 TWD
Jan 1, 2024
3.00 TWD
Jan 1, 2025
3.00 TWD
| YEAR | AAQS | YoY |
|---|---|---|
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Center Laboratories Stock analysis
What does Center Laboratories do? Center Laboratories Inc is a pharmaceutical manufacturer and distributor headquartered in Taipei City, Taiwan. Listed on the Taiwan Stock Exchange under ticker 4123.TWO and ISIN TW0004123005, the company engages in the manufacture, wholesale, and retail of western medicines. Its main product lines include dairy products and probiotic products. Center Laboratories distributes its offerings in both domestic and overseas markets. The company conducted its initial public offering on December 18, 2002. It operates within the Health Care sector, specifically in the Pharmaceuticals industry. The company's official website is https://www.centerlab.com.tw. Center Laboratories is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Center Laboratories stock
The AAQS of Center Laboratories is 3 in 2025.
On Eulerpool you can find the complete historical development of The AAQS Center Laboratories since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Center Laboratories
All Key Metrics — Center Laboratories
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth